66
Participants
Start Date
April 9, 2007
Primary Completion Date
May 25, 2009
Study Completion Date
May 25, 2009
Valsartan
Extemporaneous suspension of valsartan, orally.
Novartis Investigative Site, Laken
Novartis Investigative Site, Antwerp
Novartis Investigative Site, Edegem
Novartis Investigative Site, Liège
Novartis Investigative Site, Cape Town
Novartis Investigative Site, Ghent
Novartis Investigative Site, Torino
Novartis Investigative Site, Marseille
Novartis Investigative Site, Philadelphia
Novartis Investigative Site, Norfolk
Novartis Investigative Site, Toulouse
Novartis Investigative Site, Izmir
Novartis Investigative Site, Paris
Novartis Investigative Site, Palermo
Novartis Investigative Site, Mumbai
Novartis Investigative Site, Indore
Novartis Investigative Site, Hyderabad
Novartis Investigative Site, Mangalore
Novartis Investigative Site, Chennai
Novartis Investigative Site, Hackensack
Novartis Investigative Site, Goiânia
Novartis Investigative Site, Curitiba
Novartis Investigative Site, Recife
Novartis Investigative Site, Budapest
Novartis Investigative Site, Szeged
Novartis Investigative Site, New Delhi
Novartis Investigative Site, Gdansk
Novartis Investigative Site, Krakow
Novartis Investigative Site, Lodz
Novartis Investigative Site, Poznan
Novartis Investigative Site, Szczecin
Novartis Investigative Site, Warsaw
Novartis Investigative Site, Gezina
Novartis Investigative Site, Potchefstroom
Novartis Investigative Site, Pretoria
Novartis Investigative Site, Ankara
Lead Sponsor
Novartis Pharmaceuticals
INDUSTRY